Literature DB >> 10675352

Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice.

O Gavrilova1, B Marcus-Samuels, D Graham, J K Kim, G I Shulman, A L Castle, C Vinson, M Eckhaus, M L Reitman.   

Abstract

In lipoatrophic diabetes, a lack of fat is associated with insulin resistance and hyperglycemia. This is in striking contrast to the usual association of diabetes with obesity. To understand the underlying mechanisms, we transplanted adipose tissue into A-ZIP/F-1 mice, which have a severe form of lipoatrophic diabetes. Transplantation of wild-type fat reversed the hyperglycemia, dramatically lowered insulin levels, and improved muscle insulin sensitivity, demonstrating that the diabetes in A-ZIP/F-1 mice is caused by the lack of adipose tissue. All aspects of the A-ZIP/F-1 phenotype including hyperphagia, hepatic steatosis, and somatomegaly were either partially or completely reversed. However, the improvement in triglyceride and FFA levels was modest. Donor fat taken from parametrial and subcutaneous sites was equally effective in reversing the phenotype. The beneficial effects of transplantation were dose dependent and required near-physiological amounts of transplanted fat. Transplantation of genetically modified fat into A-ZIP/F-1 mice is a new and powerful technique for studying adipose physiology and the metabolic and endocrine communication between adipose tissue and the rest of the body.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10675352      PMCID: PMC377444          DOI: 10.1172/JCI7901

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus.

Authors:  P J RANDLE; P B GARLAND; C N HALES; E A NEWSHOLME
Journal:  Lancet       Date:  1963-04-13       Impact factor: 79.321

Review 2.  Regional adiposity and morbidity.

Authors:  A H Kissebah; G R Krakower
Journal:  Physiol Rev       Date:  1994-10       Impact factor: 37.312

Review 3.  Generalized lipodystrophy, congenital and acquired (lipoatrophy).

Authors:  M Seip; O Trygstad
Journal:  Acta Paediatr Suppl       Date:  1996-06

4.  Adipose tissue: contributions of nature and nurture to the obesity of an obese mutant mouse (ob/ob).

Authors:  M Ashwell; C J Meade; P Medawar; C Sowter
Journal:  Proc R Soc Lond B Biol Sci       Date:  1977-01-14

5.  Dietary obesity in nine inbred mouse strains.

Authors:  D B West; C N Boozer; D L Moody; R L Atkinson
Journal:  Am J Physiol       Date:  1992-06

6.  A gene for congenital generalized lipodystrophy maps to human chromosome 9q34.

Authors:  A Garg; R Wilson; R Barnes; E Arioglu; Z Zaidi; F Gurakan; N Kocak; S O'Rahilly; S I Taylor; S B Patel; A M Bowcock
Journal:  J Clin Endocrinol Metab       Date:  1999-09       Impact factor: 5.958

7.  Transplantation of human adipose tissue to nude mice.

Authors:  N Bach-Mortensen; P Romert; S Ballegaard
Journal:  Acta Pathol Microbiol Scand C       Date:  1976-08

8.  Targeted expression of a toxin gene to adipose tissue: transgenic mice resistant to obesity.

Authors:  S R Ross; R A Graves; B M Spiegelman
Journal:  Genes Dev       Date:  1993-07       Impact factor: 11.361

9.  Positional cloning of the mouse obese gene and its human homologue.

Authors:  Y Zhang; R Proenca; M Maffei; M Barone; L Leopold; J M Friedman
Journal:  Nature       Date:  1994-12-01       Impact factor: 49.962

10.  Plasma free fatty acids decrease insulin-stimulated skeletal muscle glucose uptake by suppressing glycolysis in conscious rats.

Authors:  J K Kim; J K Wi; J H Youn
Journal:  Diabetes       Date:  1996-04       Impact factor: 9.461

View more
  157 in total

1.  Unraveling the mechanism of action of thiazolidinediones.

Authors:  C R Kahn; L Chen; S E Cohen
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

Review 2.  Cellular mechanisms of insulin resistance.

Authors:  G I Shulman
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

3.  Leptin: a novel therapeutic role in lipodystrophy.

Authors:  D B Savage; S O'Rahilly
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

Review 4.  Insulin resistance and cardiovascular disease.

Authors:  H N Ginsberg
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 5.  Obesity and insulin resistance.

Authors:  B B Kahn; J S Flier
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 6.  Lipoatrophic diabetes and other related syndromes.

Authors:  Elif Arioglu Oral
Journal:  Rev Endocr Metab Disord       Date:  2003-03       Impact factor: 6.514

Review 7.  Ectopic fat accumulation: an important cause of insulin resistance in humans.

Authors:  Hannele Yki-Järvinen
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

8.  The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia.

Authors:  Kathleen Mulligan; Hootan Khatami; Jean-Marc Schwarz; Giorgos K Sakkas; Alex M DePaoli; Viva W Tai; Michael J Wen; Grace A Lee; Carl Grunfeld; Morris Schambelan
Journal:  J Clin Endocrinol Metab       Date:  2009-01-27       Impact factor: 5.958

Review 9.  Lipid-induced insulin resistance in the liver: role of exercise.

Authors:  Christos S Katsanos
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

Review 10.  Conjugated linoleic acid in humans: regulation of adiposity and insulin sensitivity.

Authors:  J Mark Brown; Michael K McIntosh
Journal:  J Nutr       Date:  2003-10       Impact factor: 4.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.